BridgeBio Oncology Therapeutics Inc.
BBOT | NASDAQ
$4.66
$0 (0.00%)
Sep 22, 2026, 12:33 PM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q4 2022 Dec 30, 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
PE Ratio | -0.01 | -1.57 | -2.36 | -2.95 | -3.83 | -7.69 | -21.88 | -17.42 | 73.21 | 215 | -5.1K | n/a | -58.74S |
PEG Ratio | n/a | -0.20 | 0.07 | -0.05 | -0.13 | 0.01 | 0.19 | 0.02 | 0.83 | -0.08 | n/a | n/a | n/a |
PS Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
PB Ratio | 0 | 0.75 | 0.95 | 0.61 | -1.10 | -1.33 | 0.93 | 1.32 | 1.31 | 1.25 | -3.28K | n/a | n/a |
P/FCF Ratio | 0 | -1.61 | -2.83 | -2.85 | -3.92 | -6.60 | -3.61 | -5.09 | -27.05 | -25.57 | n/a | n/a | n/a |
P/OCF Ratio | 0 | -1.62 | -2.85 | -2.87 | -3.93 | -6.61 | -3.61 | -5.09 | -27.09 | -25.61 | n/a | n/a | n/a |
OCF/S Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Debt / Equity Ratio | 0.01 | 0.01 | 0.01 | 0.01 | -0.01 | -0.01 | n/a | n/a | n/a | n/a | -1.10 | -1.98 | n/a |
Quick Ratio | 4.69 | 6.16 | 12.14 | 13.33 | 5.22 | 5.87 | 10.40 | 16.12 | 26.23 | 90.42 | n/a | n/a | n/a |
Current Ratio | 4.69 | 6.16 | 12.14 | 13.33 | 5.22 | 5.87 | 10.40 | 16.12 | 26.23 | 90.42 | n/a | n/a | n/a |
Asset Turnover | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Interest Coverage | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Return on Equity | -17.47% | -11.31% | -9.44% | -10.02% | 12.49% | 11.03% | -10.43% | -9.28% | -11.84% | -8.49% | 65.59% | n/a | n/a |
Return on Assets | -14.99% | -10.08% | -8.65% | -9.23% | -18.80% | -14.72% | -10.13% | -9.01% | -11.49% | -8.23% | -12.52% | n/a | n/a |
Return on Invested Capital | -18.48% | -12.32% | -10.49% | -10.94% | -24.21% | -18.39% | -11.26% | -10.23% | -12.58% | -8.24% | -638.86% | n/a | n/a |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Net Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Add to Watchlist
Select watchlists to add or remove BBOT